Synairgen (SNG)

 

Latest News

Interim results for six months ended 30 June 2017

RNS Number: 8967R Synairgen plc 27 September 2017 Press release Synairgen plc ('Synairgen' or the 'Company') Interim results for the six months ended 30 June 2017 Southampton, UK - 27 September 2017: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces its unaudited interim results for the six months ended 30 J...

Data update and clinical plan for COPD

RNS Number: 8968R Synairgen plc 27 September 2017 Press release Synairgen plc ('Synairgen' or the 'Company') Data update from clinical trial of inhaled interferon beta (SNG001) and clinical plan for COPD - Significant positive findings in patients with a confirmed viral infection in the INEXAS trial - COPD Phase II clinical trial designed Southampton, UK - 27 Sep...

Holding(s) in Company

RNS Number: 6531Q Synairgen plc 13 September 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Synairgen Plc 1b. Pleas...

Synairgen's PXS-5382A to be prepared for Phase I clinical development

Synairgen announced following the successful completion of preclinical pharmacology and toxicology studies, a compound...

All News

DateHeadlineSource
27-09-17Interim results for six months ended 30 June 2017RNS
27-09-17Data update and clinical plan for COPDRNS
13-09-17Holding(s) in CompanyRNS
06-09-17Synairgen's PXS-5382A to be prepared for Phase I clinical developmentStockMarketWire
06-09-17LOXL2 Inhibitor Update.RNS
28-06-17Synairgen shareholders pass all resolutions at AGMStockMarketWire
28-06-17Result of AGMRNS
05-06-17Posting of Annual Report and Notice of AGMRNS
17-05-17Preliminary ResultsRNS
27-04-17US tax reform plans and ex-dividends push FTSE lower StockMarketWire
27-04-17Synairgen updates on AZD9412StockMarketWire
27-04-17AZD9412 UpdateRNS
27-03-17Holding(s) in CompanyRNS
13-03-17Holding(s) in CompanyRNS
10-03-17Additional Positive Data in Lung FibrosisRNS
17-01-17Holding(s) in CompanyRNS
13-10-16Holding(s) in CompanyRNS
12-10-16Synairgen updates on AZD9412StockMarketWire
12-10-16FTSE up on airlines, house builders after sluggish startStockMarketWire
12-10-16AZD9412 Clinical Trial UpdateRNS
22-09-16Broker Forecast - N+1 Singer issues a broker note on Synairgen PLCStockMarketWire
22-09-16Synairgen widens H1 pretax lossStockMarketWire
22-09-16Interim results for six months ended 30 June 2016RNS
08-09-16Notice of Interim ResultsRNS
14-06-16Result of AGMRNS
07-06-16Are Synairgen plc or Immupharma plc better investments than AstraZeneca plc?Motley Fool
17-05-16Posting of Annual Report and Notice of AGMRNS
21-04-16Holding(s) in CompanyRNS
23-03-16Synairgen options exercised StockMarketWire
23-03-16Exercise of OptionsRNS
22-03-16Broker Forecast - finnCap issues a broker note on Synairgen PLCStockMarketWire
22-03-16Positive LOXL2 resultsRNS
22-03-16Preliminary results for the year ended 31 Dec 2015RNS
03-03-16Notice of Preliminary ResultsRNS
16-11-15Adoption of FRS 101 - Reduced Disclosure FrameworkRNS
13-11-15Holding(s) in CompanyRNS
13-11-15Holding(s) in CompanyRNS
13-11-15Holding(s) in CompanyRNS
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire
12-11-15Director Deals - Synairgen PLC (SNG)StockMarketWire

RSS feeds

  • Editorial news feed for LSE:SNG Editorial
  • Regulatory news feed for LSE:SNG Regulatory